BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

228 related articles for article (PubMed ID: 25717032)

  • 1. Activation of NRF2 by p62 and proteasome reduction in sphere-forming breast carcinoma cells.
    Ryoo IG; Choi BH; Kwak MK
    Oncotarget; 2015 Apr; 6(10):8167-84. PubMed ID: 25717032
    [TBL] [Abstract][Full Text] [Related]  

  • 2. High CD44 expression mediates p62-associated NFE2L2/NRF2 activation in breast cancer stem cell-like cells: Implications for cancer stem cell resistance.
    Ryoo IG; Choi BH; Ku SK; Kwak MK
    Redox Biol; 2018 Jul; 17():246-258. PubMed ID: 29729523
    [TBL] [Abstract][Full Text] [Related]  

  • 3. High NRF2 level mediates cancer stem cell-like properties of aldehyde dehydrogenase (ALDH)-high ovarian cancer cells: inhibitory role of all-trans retinoic acid in ALDH/NRF2 signaling.
    Kim D; Choi BH; Ryoo IG; Kwak MK
    Cell Death Dis; 2018 Aug; 9(9):896. PubMed ID: 30166520
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Oxidative stress, mammospheres and Nrf2-new implication for breast cancer therapy?
    Wu T; Harder BG; Wong PK; Lang JE; Zhang DD
    Mol Carcinog; 2015 Nov; 54(11):1494-502. PubMed ID: 25154499
    [TBL] [Abstract][Full Text] [Related]  

  • 5. PA-MSHA inhibits the growth of doxorubicin-resistant MCF-7/ADR human breast cancer cells by downregulating Nrf2/p62.
    Wei Y; Liu D; Jin X; Gao P; Wang Q; Zhang J; Zhang N
    Cancer Med; 2016 Dec; 5(12):3520-3531. PubMed ID: 27758045
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Suppression of Nrf2 Activity by Chestnut Leaf Extract Increases Chemosensitivity of Breast Cancer Stem Cells to Paclitaxel.
    Woo Y; Oh J; Kim JS
    Nutrients; 2017 Jul; 9(7):. PubMed ID: 28718813
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Increased proteasome subunit protein expression and proteasome activity in colon cancer relate to an enhanced activation of nuclear factor E2-related factor 2 (Nrf2).
    Arlt A; Bauer I; Schafmayer C; Tepel J; Müerköster SS; Brosch M; Röder C; Kalthoff H; Hampe J; Moyer MP; Fölsch UR; Schäfer H
    Oncogene; 2009 Nov; 28(45):3983-96. PubMed ID: 19734940
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Nuclear Factor Erythroid-Derived 2-Like 2-Induced Reductive Stress Favors Self-Renewal of Breast Cancer Stem-Like Cells
    Kim DH; Jang JH; Kwon OS; Cha HJ; Youn HJ; Chun KS; Surh YJ
    Antioxid Redox Signal; 2020 Jun; 32(18):1313-1329. PubMed ID: 31672029
    [No Abstract]   [Full Text] [Related]  

  • 9. 15-Deoxy-delta 12, 14-prostaglandin J2 induces upregulation of multidrug resistance-associated protein 1 via Nrf2 activation in human breast cancer cells.
    Song NY; Kim DH; Kim EH; Na HK; Surh YJ
    Ann N Y Acad Sci; 2009 Aug; 1171():210-6. PubMed ID: 19723058
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Chemotherapeutic resistance of head and neck squamous cell carcinoma is mediated by EpCAM induction driven by IL-6/p62 associated Nrf2-antioxidant pathway activation.
    Noman ASM; Parag RR; Rashid MI; Islam S; Rahman MZ; Chowdhury AA; Sultana A; Jerin C; Siddiqua A; Rahman L; Nayeem J; Akther S; Baidya S; Shil RK; Rahman M; Shirin A; Mahmud R; Hossain SMI; Sumi SA; Chowdhury A; Basher SB; Hasan A; Bithy S; Aklima J; Chowdhury N; Hasan MN; Banu T; Chowdhury S; Hossain MM; Yeger H; Farhat WA; Islam SS
    Cell Death Dis; 2020 Aug; 11(8):663. PubMed ID: 32814771
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Noncanonical SQSTM1/p62-Nrf2 pathway activation mediates proteasome inhibitor resistance in multiple myeloma cells via redox, metabolic and translational reprogramming.
    Riz I; Hawley TS; Marsal JW; Hawley RG
    Oncotarget; 2016 Oct; 7(41):66360-66385. PubMed ID: 27626179
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Neuropilin-1 is expressed by breast cancer stem-like cells and is linked to NF-κB activation and tumor sphere formation.
    Glinka Y; Mohammed N; Subramaniam V; Jothy S; Prud'homme GJ
    Biochem Biophys Res Commun; 2012 Sep; 425(4):775-80. PubMed ID: 22885184
    [TBL] [Abstract][Full Text] [Related]  

  • 13. p38(MAPK)-regulated induction of p62 and NBR1 after photodynamic therapy promotes autophagic clearance of ubiquitin aggregates and reduces reactive oxygen species levels by supporting Nrf2-antioxidant signaling.
    Rubio N; Verrax J; Dewaele M; Verfaillie T; Johansen T; Piette J; Agostinis P
    Free Radic Biol Med; 2014 Feb; 67():292-303. PubMed ID: 24269898
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Multidrug resistance-associated protein 1 mediates 15-deoxy-Δ(12,14)-prostaglandin J2-induced expression of glutamate cysteine ligase expression via Nrf2 signaling in human breast cancer cells.
    Song NY; Kim DH; Kim EH; Na HK; Kim NJ; Suh YG; Surh YJ
    Chem Res Toxicol; 2011 Aug; 24(8):1231-41. PubMed ID: 21728338
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mammospheres of hormonal receptor positive breast cancer diverge to triple-negative phenotype.
    Laranjo M; Carvalho MJ; Costa T; Alves A; Oliveira RC; Casalta-Lopes J; Cordeiro P; Botas F; Abrantes AM; Paiva A; Oliveira C; Botelho MF
    Breast; 2018 Apr; 38():22-29. PubMed ID: 29182983
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Estrogen increases Nrf2 activity through activation of the PI3K pathway in MCF-7 breast cancer cells.
    Wu J; Williams D; Walter GA; Thompson WE; Sidell N
    Exp Cell Res; 2014 Nov; 328(2):351-60. PubMed ID: 25172557
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Redox Modulating NRF2: A Potential Mediator of Cancer Stem Cell Resistance.
    Ryoo IG; Lee SH; Kwak MK
    Oxid Med Cell Longev; 2016; 2016():2428153. PubMed ID: 26682001
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The involvement of p62-Keap1-Nrf2 antioxidative signaling pathway and JNK in the protection of natural flavonoid quercetin against hepatotoxicity.
    Ji LL; Sheng YC; Zheng ZY; Shi L; Wang ZT
    Free Radic Biol Med; 2015 Aug; 85():12-23. PubMed ID: 25881548
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of fibroblasts on breast cancer cell mammosphere formation and regulation of stem cell-related gene expression.
    Zhang F; Song C; Ma Y; Tang L; Xu Y; Wang H
    Int J Mol Med; 2011 Sep; 28(3):365-71. PubMed ID: 21573501
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mitochondria as new therapeutic targets for eradicating cancer stem cells: Quantitative proteomics and functional validation via MCT1/2 inhibition.
    Lamb R; Harrison H; Hulit J; Smith DL; Lisanti MP; Sotgia F
    Oncotarget; 2014 Nov; 5(22):11029-37. PubMed ID: 25415228
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.